These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 34742934)
21. Ginsenoside Rg Shi Y; Chen J; Qu D; Sun Q; Yu Y; Zhang H; Liu Z; Sha J; Sun Y Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542753 [TBL] [Abstract][Full Text] [Related]
22. Deletion of the PPARδ gene exacerbates high-fat diet-induced nonalcoholic fatty liver disease in mice through the gut-liver axis. Wang YT; Wang FF; Li H; Xu JY; Lu XL; Wang Y Cell Mol Biol (Noisy-le-grand); 2023 Oct; 69(10):121-128. PubMed ID: 37953575 [TBL] [Abstract][Full Text] [Related]
23. Oroxin B improves metabolic-associated fatty liver disease by alleviating gut microbiota dysbiosis in a high-fat diet-induced rat model. Huang Y; Wang C; Wang M; Xiong T; Song X; Sun W; Li J Eur J Pharmacol; 2023 Jul; 951():175788. PubMed ID: 37179040 [TBL] [Abstract][Full Text] [Related]
24. Tian G; Wang W; Xia E; Chen W; Zhang S Front Cell Infect Microbiol; 2023; 13():1078447. PubMed ID: 36860985 [TBL] [Abstract][Full Text] [Related]
25. Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice. Song H; Chu Q; Yan F; Yang Y; Han W; Zheng X J Gastroenterol Hepatol; 2016 Aug; 31(8):1462-9. PubMed ID: 26699443 [TBL] [Abstract][Full Text] [Related]
26. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats. Zhang Y; Tang K; Deng Y; Chen R; Liang S; Xie H; He Y; Chen Y; Yang Q Biomed Pharmacother; 2018 Jun; 102():1025-1036. PubMed ID: 29710519 [TBL] [Abstract][Full Text] [Related]
27. [Zuogui Jiangtang Qinggan Prescription promotes recovery of intestinal mucosal barrier in mice with type 2 diabetes mellitus and nonalcoholic fatty liver disease by improving intestinal flora homeostasis]. Zou JJ; Li H; Zhou M; Huang QQ; Wu YJ; Yu R Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(2):525-533. PubMed ID: 36725242 [TBL] [Abstract][Full Text] [Related]
28. Branched Chain Amino Acids Cause Liver Injury in Obese/Diabetic Mice by Promoting Adipocyte Lipolysis and Inhibiting Hepatic Autophagy. Zhang F; Zhao S; Yan W; Xia Y; Chen X; Wang W; Zhang J; Gao C; Peng C; Yan F; Zhao H; Lian K; Lee Y; Zhang L; Lau WB; Ma X; Tao L EBioMedicine; 2016 Nov; 13():157-167. PubMed ID: 27843095 [TBL] [Abstract][Full Text] [Related]
29. Wang B; Kong Q; Cui S; Li X; Gu Z; Zhao J; Zhang H; Chen W; Wang G Nutrients; 2021 Mar; 13(3):. PubMed ID: 33801119 [TBL] [Abstract][Full Text] [Related]
30. Procyanidin B2 protects against diet-induced obesity and non-alcoholic fatty liver disease Xing YW; Lei GT; Wu QH; Jiang Y; Huang MX World J Gastroenterol; 2019 Feb; 25(8):955-966. PubMed ID: 30833801 [TBL] [Abstract][Full Text] [Related]
31. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota. Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192 [TBL] [Abstract][Full Text] [Related]
32. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis. Wang P; Wang J; Li D; Ke W; Chen F; Hu X J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250 [TBL] [Abstract][Full Text] [Related]
33. Tangshen formula targets the gut microbiota to treat non-alcoholic fatty liver disease in HFD mice: A 16S rRNA and non-targeted metabolomics analyses. Wang S; Li X; Zhang B; Li Y; Chen K; Qi H; Gao M; Rong J; Liu L; Wan Y; Dong X; Yan M; Ma L; Li P; Zhao T Biomed Pharmacother; 2024 Apr; 173():116405. PubMed ID: 38484559 [TBL] [Abstract][Full Text] [Related]
34. Activation of estrogen receptor α (ERα) is required for Alisol B23-acetate to prevent post-menopausal atherosclerosis and reduced lipid accumulation. Chen Q; Chao Y; Zhang W; Zhang Y; Bi Y; Fu Y; Cai D; Meng Q; Li Y; Bian H Life Sci; 2020 Oct; 258():118030. PubMed ID: 32739470 [TBL] [Abstract][Full Text] [Related]
35. Specific Strains of Hu W; Gao W; Liu Z; Fang Z; Wang H; Zhao J; Zhang H; Lu W; Chen W Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889903 [TBL] [Abstract][Full Text] [Related]
36. Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis. Vitaglione P; Mazzone G; Lembo V; D'Argenio G; Rossi A; Guido M; Savoia M; Salomone F; Mennella I; De Filippis F; Ercolini D; Caporaso N; Morisco F J Nutr Sci; 2019; 8():e15. PubMed ID: 31037218 [TBL] [Abstract][Full Text] [Related]
37. Mu J; Tan F; Zhou X; Zhao X Food Funct; 2020 Oct; 11(10):8707-8723. PubMed ID: 32945305 [TBL] [Abstract][Full Text] [Related]
38. Tectorigenin ameliorated high-fat diet-induced nonalcoholic fatty liver disease through anti-inflammation and modulating gut microbiota in mice. Duan R; Huang K; Guan X; Li S; Xia J; Shen M; Sun Z; Yu Z Food Chem Toxicol; 2022 Jun; 164():112948. PubMed ID: 35390440 [TBL] [Abstract][Full Text] [Related]
39. Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice. Porras D; Nistal E; Martínez-Flórez S; Olcoz JL; Jover R; Jorquera F; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S Mol Nutr Food Res; 2019 Apr; 63(8):e1800930. PubMed ID: 30680920 [TBL] [Abstract][Full Text] [Related]
40. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NF Ding X; Jian T; Li J; Lv H; Tong B; Li J; Meng X; Ren B; Chen J Oxid Med Cell Longev; 2020; 2020():9734560. PubMed ID: 33204402 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]